References
Deem S, Diringer M, Livesay S, Treggiari MM. Hemodynamic management in the prevention and treatment of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2023. https://doi.org/10.1007/s12028-023-01738-w.
Castle-Kirszbaum M, Lai L, Maingard J, Asadi H, Danks RA, Goldschlager T, et al. Intravenous milrinone for treatment of delayed cerebral ischaemia following subarachnoid haemorrhage: a pooled systematic review. Neurosurg Rev. 2021;44:3107–24.
Joseph M, Ziadi S, Nates J, Dannenbaum M, Malkoff M. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow. Neurosurgery. 2003;53:1044–51.
Fraticelli AT, Cholley BP, Losser M-R, Saint Maurice J-P, Payen D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39:893–8.
Lakhal K, Hivert A, Alexandre P-L, Fresco M, Robert-Edan V, Rodie-Talbere P-A, et al. Intravenous milrinone for cerebral vasospasm in subarachnoid hemorrhage: the MILRISPASM controlled before-after study. Neurocrit Care. 2021;35:669–79.
Funding
No funding was required for this Letter to the Editor.
Author information
Authors and Affiliations
Contributions
KL drafting the manuscript. VRE: drafting the manuscript. The final manuscript was approved by all authors.
Corresponding author
Ethics declarations
Conflict of interest
Vincent Robert-Edan has no conflict of interest in connection with the work submitted. In addition, VRE received, during the past 3 years, travel fees from Pfizer (once, in 2020). Karim Lakhal has no conflict of interest in connection with the work submitted. In addition, KL received, during the past 3 years, congress registration from Pfizer (once in 2022) and both congress registration and travel fees from Pfizer (twice, in 2020) and Advanz Pharma/Correvio (twice, in 2020 and once in 2021).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The article is related to the response letter is available at https://doi.org/10.1007/s12028-023-01790-6. This article is related to the original work available at https://link.springer.com/article/10.1007/s12028-023-01738-w.
Rights and permissions
About this article
Cite this article
Robert-Edan, V., Lakhal, K. Treating Vasospasm with IV Milrinone: Relax (The Vessel) or Don’t Do It!. Neurocrit Care 39, 547–548 (2023). https://doi.org/10.1007/s12028-023-01789-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-023-01789-z